Article
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Malaria journal - 24 Feb 2016
Win Aye A, Imwong Mallika, Kyaw Myat P, Woodrow Charles J, Chotivanich Kesinee, Hanboonkunupakarn Borimas, Pukrittayakamee Sasithon
Abstract excerpt
BACKGROUND: Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Myanmar-Thailand border raise concerns over resistance patterns in Myanmar. The availability of molecular markers for resistance to both drugs enables assessment even...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
